FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermid/File Photo ...

Merck's monoclonal antibody, called clesrovimab and branded as Enflonsia, is the first and only preventive shot that can be administered as a single dose regardless of birth weight in healthy pre-term ...

(Reuters) -Merck's oral cholesterol pill succeeded in two late-stage studies, marking a win for the drugmaker as it focuses on the development of growth drivers beyond its cancer drugs and vaccines.

(Reuters) -Merck said on Monday its drug met the main goal of reducing a type of cholesterol in two late-stage studies. ... Merck logo is seen in this illustration taken March 26, 2025.

FILE PHOTO: Merck logo is seen in this illustration taken March 26, 2025. REUTERS/Dado Ruvic/Illustration (Reuters) -Merck's oral cholesterol pill succeeded in two late-stage studies, ...

The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermid/File Photo Purchase Licensing Rights, opens new tab.

Merck's monoclonal antibody, called clesrovimab and branded as Enflonsia, is the first and only preventive shot that can be administered as a single dose regardless of birth weight in healthy pre-term ...

Merck's monoclonal antibody, called clesrovimab and branded as Enflonsia, is the first and only preventive shot that can be administered as a single dose regardless of birth weight in healthy pre ...

Dr. Reddy’s, Alvotech to co-develop, market biosimilar of Merck’s cancer drug Keytruda Worldwide sales of Keytruda in 2024 were $29.5 billion Updated - June 05, 2025 02:46 pm IST - HYDERABAD ...